SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 257.38M
March 31, 2026 251.24M
December 31, 2025 254.94M
September 30, 2025 267.54M
June 30, 2025 277.85M
March 31, 2025 290.65M
December 31, 2024 297.37M
September 30, 2024 302.74M
June 30, 2024 305.65M
March 31, 2024 307.28M
December 31, 2023 302.31M
September 30, 2023 316.28M
June 30, 2023 306.06M
March 31, 2023 288.73M
December 31, 2022 283.90M
September 30, 2022 252.06M
June 30, 2022 267.81M
March 31, 2022 267.50M
December 31, 2021 260.88M
September 30, 2021 252.10M
June 30, 2021 220.82M
March 31, 2021 222.71M
December 31, 2020 220.62M
September 30, 2020 228.04M
June 30, 2020 232.32M
Date Value
March 31, 2020 225.20M
December 31, 2019 217.76M
September 30, 2019 211.96M
June 30, 2019 204.79M
March 31, 2019 194.34M
December 31, 2018 182.64M
September 30, 2018 167.02M
June 30, 2018 164.31M
March 31, 2018 162.18M
December 31, 2017 159.03M
September 30, 2017 153.06M
June 30, 2017 141.09M
March 31, 2017 132.93M
December 31, 2016 128.10M
September 30, 2016 130.26M
June 30, 2016 127.09M
March 31, 2016 123.06M
December 31, 2015 119.98M
September 30, 2015 115.27M
June 30, 2015 113.13M
March 31, 2015 115.35M
December 31, 2014 114.37M
September 30, 2014 111.73M
June 30, 2014 111.66M
March 31, 2014 104.22M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Agilent Technologies, Inc. 1.844B
Bio-Rad Laboratories, Inc. 852.20M
Bruker Corp. 970.70M
Danaher Corp. 7.949B
Harvard Bioscience, Inc. 38.06M